1 Department of Medicine (DIMED), University of Padova, Padova, Italy
| 2 Department of Nephrology, Dialysis and Transplantation, Fondazione International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Vicenza, Italy
| 3 Department of Kidney Transplantation, Clínica de Doenças Renais de Brasília-DF Star Hospital, Brasília, Brazil
| 4 Laboratory of Molecular Pharmacology, University of Brasília, Brasília, Brazil
RoncoC, McCulloughPA, AnkerSD, AnandI, AspromonteN, BagshawSM, et al.: Cardiorenal Syndromes: An Executive Summary from the Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). In: Contributions to Nephrology, edited by RoncoC, BellomoR, McCulloughPA, Basel, Karger, 2010, pp 54–67, https://doi.org/10.1159/000313745PubMed
RoncoC, McCulloughPA, AnkerSD, AnandI, AspromonteN, BagshawSM, : Cardiorenal Syndromes: An Executive Summary from the Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). In: Contributions to Nephrology, edited by RoncoC, BellomoR, McCulloughPA, Basel, Karger, 2010, pp 54–67, https://doi.org/10.1159/000313745PubMed)| false
ArrigoM, GayatE, ParenicaJ, IshiharaS, ZhangJ, ChoiDJ, et al.; GREAT Network: Precipitating factors and 90-day outcome of acute heart failure: A report from the intercontinental GREAT registry. Eur J Heart Fail19: 201–208, 2017https://doi.org/10.1002/ejhf.682PubMed
ArrigoM, GayatE, ParenicaJ, IshiharaS, ZhangJ, ChoiDJ, ; GREAT Network: Precipitating factors and 90-day outcome of acute heart failure: A report from the intercontinental GREAT registry. Eur J Heart Fail 19: 201–208, 2017https://doi.org/10.1002/ejhf.682PubMed10.1002/ejhf.682)| false
BoorsmaEM, Ter MaatenJM, DammanK, DinhW, GustafssonF, GoldsmithS, et al.: Congestion in heart failure: A contemporary look at physiology, diagnosis and treatment. Nat Rev Cardiol17: 641–655, 2020https://doi.org/10.1038/s41569-020-0379-7PubMed
NadimMK, ForniLG, BihoracA, HobsonC, KoynerJL, ShawA, et al.: Cardiac and vascular surgery–associated acute kidney injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc2018;7. https://doi.org/10.1161/JAHA.118.008834
BaranDA, GrinesCL, BaileyS, BurkhoffD, HallSA, HenryTD, et al.: SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv94: 29–37, 2019https://doi.org/10.1002/ccd.28329PubMed
BaranDA, GrinesCL, BaileyS, BurkhoffD, HallSA, HenryTD, : SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv 94: 29–37, 2019https://doi.org/10.1002/ccd.28329PubMed)| false
de ChambrunMP, DonkerDW, CombesA: What’s new in cardiogenic shock?Intensive Care Med46: 1016–1019, 2020https://doi.org/10.1007/s00134-020-05973-zPubMed
de ChambrunMP, DonkerDW, CombesA: What’s new in cardiogenic shock?Intensive Care Med 46: 1016–1019, 2020https://doi.org/10.1007/s00134-020-05973-zPubMed10.1007/s00134-020-05973-z)| false
JentzerJC, van DiepenS, BarsnessGW, HenryTD, MenonV, RihalCS, et al.: Cardiogenic shock classification to predict mortality in the cardiac intensive care unit. J Am Coll Cardiol74: 2117–2128, 2019https://doi.org/10.1016/j.jacc.2019.07.077PubMed
JentzerJC, van DiepenS, BarsnessGW, HenryTD, MenonV, RihalCS, : Cardiogenic shock classification to predict mortality in the cardiac intensive care unit. J Am Coll Cardiol 74: 2117–2128, 2019https://doi.org/10.1016/j.jacc.2019.07.077PubMed10.1016/j.jacc.2019.07.077)| false
ForniLG, JoannidisM: Blood pressure deficits in acute kidney injury: Not all about the mean arterial pressure?Crit Care21: 102, 2017https://doi.org/10.1186/s13054-017-1683-4PubMed
ForniLG, JoannidisM: Blood pressure deficits in acute kidney injury: Not all about the mean arterial pressure?Crit Care 21: 102, 2017https://doi.org/10.1186/s13054-017-1683-4PubMed10.1186/s13054-017-1683-4)| false
SomanS, AuroraL: Type 3 cardiorenal syndrome. In: Textbook of Cardiorenal Medicine, edited by McCulloughPA, RoncoC, New York, Springer International Publishing, 2021, pp 95–110, https://doi.org/10.1007/978-3-030-57460-4_9
SomanS, AuroraL: Type 3 cardiorenal syndrome. In: Textbook of Cardiorenal Medicine, edited by McCulloughPA, RoncoC, New York, Springer International Publishing, 2021, pp 95–110, https://doi.org/10.1007/978-3-030-57460-4_910.1007/978-3-030-57460-4_9)| false
Di LulloL, RoncoC: Type-5 cardiorenal syndrome. In: Textbook of Cardiorenal Medicine, edited by McCulloughPA, RoncoC, New York, Springer International Publishing, 2021, pp 111–124, https://doi.org/10.1007/978-3-030-57460-4_10
Di LulloL, RoncoC: Type-5 cardiorenal syndrome. In: Textbook of Cardiorenal Medicine, edited by McCulloughPA, RoncoC, New York, Springer International Publishing, 2021, pp 111–124, https://doi.org/10.1007/978-3-030-57460-4_1010.1007/978-3-030-57460-4_10)| false
LandesbergG, GilonD, MerozY, GeorgievaM, LevinPD, GoodmanS, et al.: Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J33: 895–903, 2012https://doi.org/10.1093/eurheartj/ehr351PubMed
McMurrayJJV, PackerM, DesaiAS, GongJ, LefkowitzMP, RizkalaAR, et al.; PARADIGM-HF Investigators and Committees: Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med371: 993–1004, 2014https://doi.org/10.1056/NEJMoa1409077PubMed
JamesM, MannsB: Neprilysin inhibition and effects on kidney function and surrogates of cardiovascular risk in chronic kidney disease. Circulation138: 1515–1518, 2018https://doi.org/10.1161/CIRCULATIONAHA.118.036523PubMed
JamesM, MannsB: Neprilysin inhibition and effects on kidney function and surrogates of cardiovascular risk in chronic kidney disease. Circulation 138: 1515–1518, 2018https://doi.org/10.1161/CIRCULATIONAHA.118.036523PubMed10.1161/CIRCULATIONAHA.118.036523)| false
HaynesR, JudgePK, StaplinN, HerringtonWG, StoreyBC, BethelA, et al.: Effects of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease. Circulation138: 1505–1514, 2018https://doi.org/10.1161/CIRCULATIONAHA.118.034818PubMed
PeppinKL, TellorKB, ArmbrusterAL, SchwarzeMW: Evaluating the safety and tolerability of inpatient sacubitril/valsartan initiation in a community hospital. J Community Hosp Intern Med Perspect10: 38–44, 2020https://doi.org/10.1080/20009666.2019.1708638PubMed
PeppinKL, TellorKB, ArmbrusterAL, SchwarzeMW: Evaluating the safety and tolerability of inpatient sacubitril/valsartan initiation in a community hospital. J Community Hosp Intern Med Perspect 10: 38–44, 2020https://doi.org/10.1080/20009666.2019.1708638PubMed10.1080/20009666.2019.1708638)| false
McMurrayJJV, SolomonSD, InzucchiSE, KøberL, KosiborodMN, MartinezFA, et al.; DAPA-HF Trial Committees and Investigators: Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med381: 1995–2008, 2019https://doi.org/10.1056/NEJMoa1911303PubMed
McMurrayJJV, SolomonSD, InzucchiSE, KøberL, KosiborodMN, MartinezFA, ; DAPA-HF Trial Committees and Investigators: Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381: 1995–2008, 2019https://doi.org/10.1056/NEJMoa1911303PubMed10.1056/NEJMoa1911303)| false
RampersadC, KrautE, WhitlockRH, KomendaP, WooV, RigattoC, et al.: Acute kidney injury events in patients with type 2 diabetes using SGLT2 inhibitors versus other glucose-lowering drugs: A retrospective cohort study. Am J Kidney Dis76: 471–479.e1, 2020https://doi.org/10.1053/j.ajkd.2020.03.019PubMed
RampersadC, KrautE, WhitlockRH, KomendaP, WooV, RigattoC, : Acute kidney injury events in patients with type 2 diabetes using SGLT2 inhibitors versus other glucose-lowering drugs: A retrospective cohort study. Am J Kidney Dis 76: 471–479.e1, 2020https://doi.org/10.1053/j.ajkd.2020.03.019PubMed10.1053/j.ajkd.2020.03.019)| false
PhadkeG, KaushalA, TolanDR, HahnK, JensenT, BjornstadP, et al.: Osmotic nephrosis and acute kidney injury associated with SGLT2 inhibitor use: A case report. Am J Kidney Dis76: 144–147, 2020https://doi.org/10.1053/j.ajkd.2020.01.015PubMed
TardifJ-C, KouzS, WatersDD, BertrandOF, DiazR, MaggioniAP, et al.: Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med381: 2497–2505, 2019https://doi.org/10.1056/NEJMoa1912388PubMed
TardifJ-C, KouzS, WatersDD, BertrandOF, DiazR, MaggioniAP, : Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 381: 2497–2505, 2019https://doi.org/10.1056/NEJMoa1912388PubMed10.1056/NEJMoa1912388)| false
GuzziLM, BerglerT, BinnallB, EngelmanDT, ForniL, GermainMJ, et al.: Clinical use of [TIMP-2]•[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: Guidance from an expert panel. Crit Care23: 225, 2019https://doi.org/10.1186/s13054-019-2504-8PubMed
GuzziLM, BerglerT, BinnallB, EngelmanDT, ForniL, GermainMJ, : Clinical use of [TIMP-2]•[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: Guidance from an expert panel. Crit Care 23: 225, 2019https://doi.org/10.1186/s13054-019-2504-8PubMed10.1186/s13054-019-2504-8)| false
OstermannM, AyisS, TuddenhamE, LoJ, LeiK, SmithJ, et al.: Cardiac troponin release is associated with biomarkers of inflammation and ventricular dilatation during critical illness. Shock47: 702–708, 2017https://doi.org/10.1097/SHK.0000000000000811PubMed
KDIGO Clinical Practice Guideline for Acute Kidney Injury: Kidney Int Suppl 2: 8–12, 2012https://doi.org/10.1038/kisup.2012.710.1038/kisup.2012.7)| false
SelbyNM, CasulaA, LammingL, StovesJ, SamarasingheY, LewingtonAJ, et al.: An organizational-level program of intervention for AKI: A pragmatic stepped wedge cluster randomized trial. J Am Soc Nephrol30: 505–515, 2019https://doi.org/10.1681/ASN.2018090886PubMed
SelbyNM, CasulaA, LammingL, StovesJ, SamarasingheY, LewingtonAJ, : An organizational-level program of intervention for AKI: A pragmatic stepped wedge cluster randomized trial. J Am Soc Nephrol 30: 505–515, 2019https://doi.org/10.1681/ASN.2018090886PubMed10.1681/ASN.2018090886)| false
LiuKD, GoldsteinSL, VijayanA, ParikhCR, KashaniK, OkusaMD, et al.; AKI!Now Initiative of the American Society of Nephrology: AKI!Now Initiative: Recommendations for awareness, recognition, and management of AKI. Clin J Am Soc Nephrol15: 1838–1847, 2020https://doi.org/10.2215/CJN.15611219PubMed
LiuKD, GoldsteinSL, VijayanA, ParikhCR, KashaniK, OkusaMD, ; AKI!Now Initiative of the American Society of Nephrology: AKI!Now Initiative: Recommendations for awareness, recognition, and management of AKI. Clin J Am Soc Nephrol 15: 1838–1847, 2020https://doi.org/10.2215/CJN.15611219PubMed10.2215/CJN.15611219)| false
JoannidisM, DrumlW, ForniLG, GroeneveldABJ, HonorePM, HosteE, et al.: Prevention of acute kidney injury and protection of renal function in the intensive care unit: Update 2017: Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med43: 730–749, 2017https://doi.org/10.1007/s00134-017-4832-yPubMed
JoannidisM, DrumlW, ForniLG, GroeneveldABJ, HonorePM, HosteE, : Prevention of acute kidney injury and protection of renal function in the intensive care unit: Update 2017: Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med 43: 730–749, 2017https://doi.org/10.1007/s00134-017-4832-yPubMed10.1007/s00134-017-4832-y)| false
ZarbockA, KüllmarM, OstermannM, LuccheseG, BaigK, CennamoA, et al.: Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: The PrevAKI-multicenter randomized controlled trial. Anesth Analg133: 292–302, 2021https://doi.org/10.1213/ANE.0000000000005458PubMed
MullensW, DammanK, HarjolaV-P, MebazaaA, Brunner-La RoccaH-P, MartensP, et al.: The use of diuretics in heart failure with congestion—A position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail21: 137–155, 2019https://doi.org/10.1002/ejhf.1369PubMed
MullensW, DammanK, HarjolaV-P, MebazaaA, Brunner-La RoccaH-P, MartensP, : The use of diuretics in heart failure with congestion—A position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21: 137–155, 2019https://doi.org/10.1002/ejhf.1369PubMed10.1002/ejhf.1369)| false
VermaS, McMurrayJJV: SGLT2 inhibitors and mechanisms of cardiovascular benefit: A state-of-the-art review. Diabetologia61: 2108–2117, 2018https://doi.org/10.1007/s00125-018-4670-7PubMed
KazoryA: Ultrafiltration therapy for heart failure: Balancing likely benefits against possible risks. Clin J Am Soc Nephrol11: 1463–1471, 2016https://doi.org/10.2215/CJN.13461215PubMed
CostanzoMR, RoncoC, AbrahamWT, AgostoniP, BaraschJ, FonarowGC, et al.: Extracorporeal ultrafiltration for fluid overload in heart failure: Current status and prospects for further research. J Am CollCardiol69: 2428–2445, 2017https://doi.org/10.1016/j.jacc.2017.03.528PubMed
CostanzoMR, RoncoC, AbrahamWT, AgostoniP, BaraschJ, FonarowGC, : Extracorporeal ultrafiltration for fluid overload in heart failure: Current status and prospects for further research. J Am CollCardiol 69: 2428–2445, 2017https://doi.org/10.1016/j.jacc.2017.03.528PubMed10.1016/j.jacc.2017.03.528)| false
MuruganR, KertiSJ, ChangCH, GallagherM, ClermontG, PalevskyPM, et al.: Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: A secondary analysis of the randomized evaluation of normal vs augmented level (RENAL) of renal replacement therapy trial. JAMA Netw Open2: e195418, 2019https://doi.org/10.1001/jamanetworkopen.2019.5418PubMed
MuruganR, KertiSJ, ChangCH, GallagherM, ClermontG, PalevskyPM, : Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: A secondary analysis of the randomized evaluation of normal vs augmented level (RENAL) of renal replacement therapy trial. JAMA Netw Open 2: e195418, 2019https://doi.org/10.1001/jamanetworkopen.2019.5418PubMed)| false
NaorungrojT, NetoAS, Zwakman-HesselsL, FumitakaY, EastwoodG, MuruganR, et al.: Mediators of the impact of hourly net ultrafiltration rate on mortality in critically ill patients receiving continuous renal replacement therapy. Crit Care Med48: e934–e942, 2020https://doi.org/10.1097/CCM.0000000000004508PubMed
NaorungrojT, NetoAS, Zwakman-HesselsL, FumitakaY, EastwoodG, MuruganR, : Mediators of the impact of hourly net ultrafiltration rate on mortality in critically ill patients receiving continuous renal replacement therapy. Crit Care Med 48: e934–e942, 2020https://doi.org/10.1097/CCM.0000000000004508PubMed10.1097/CCM.0000000000004508)| false
TehranianS, ShawwaK, KashaniKB: Net ultrafiltration rate and its impact on mortality in patients with acute kidney injury receiving continuous renal replacement therapy. Clin Kidney J14: 564–569, 2019https://doi.org/10.1093/ckj/sfz179PubMed
TehranianS, ShawwaK, KashaniKB: Net ultrafiltration rate and its impact on mortality in patients with acute kidney injury receiving continuous renal replacement therapy. Clin Kidney J 14: 564–569, 2019https://doi.org/10.1093/ckj/sfz179PubMed10.1093/ckj/sfz179)| false
RoncoC, ChawlaLS: Glomerular and tubular kidney stress test: New tools for a deeper evaluation of kidney function. Nephron134: 191–194, 2016https://doi.org/10.1159/000449235PubMed
RoncoC, ChawlaLS: Glomerular and tubular kidney stress test: New tools for a deeper evaluation of kidney function. Nephron 134: 191–194, 2016https://doi.org/10.1159/000449235PubMed10.1159/000449235)| false
PonceD, GóesC, OliveiraM, BalbiA: Peritoneal dialysis for the treatment of cardiorenal syndrome type 1: A prospective Brazilian study. Perit Dial Int37: 578–583, 2017https://doi.org/10.3747/pdi.2016.00217PubMed
PonceD, GóesC, OliveiraM, BalbiA: Peritoneal dialysis for the treatment of cardiorenal syndrome type 1: A prospective Brazilian study. Perit Dial Int 37: 578–583, 2017https://doi.org/10.3747/pdi.2016.00217PubMed10.3747/pdi.2016.00217)| false
KazoryA, BargmanJM: Defining the role of peritoneal dialysis in management of congestive heart failure. Expert Rev Cardiovasc Ther17: 533–543, 2019https://doi.org/10.1080/14779072.2019.1637254PubMed
KazoryA, BargmanJM: Defining the role of peritoneal dialysis in management of congestive heart failure. Expert Rev Cardiovasc Ther 17: 533–543, 2019https://doi.org/10.1080/14779072.2019.1637254PubMed10.1080/14779072.2019.1637254)| false
Pineton de ChambrunM, BréchotN, CombesA: The place of extracorporeal life support in cardiogenic shock. Curr Opin Crit Care26: 424–431, 2020https://doi.org/10.1097/MCC.0000000000000747PubMed
Pineton de ChambrunM, BréchotN, CombesA: The place of extracorporeal life support in cardiogenic shock. Curr Opin Crit Care 26: 424–431, 2020https://doi.org/10.1097/MCC.0000000000000747PubMed)| false
LascarrouJ-B, MerdjiH, Le GougeA, ColinG, GrilletG, GirardieP, et al.; CRICS-TRIGGERSEP Group: Targeted temperature management for cardiac arrest with nonshockable rhythm. N Engl J Med381: 2327–2337, 2019https://doi.org/10.1056/NEJMoa1906661PubMed
LascarrouJ-B, MerdjiH, Le GougeA, ColinG, GrilletG, GirardieP, ; CRICS-TRIGGERSEP Group: Targeted temperature management for cardiac arrest with nonshockable rhythm. N Engl J Med 381: 2327–2337, 2019https://doi.org/10.1056/NEJMoa1906661PubMed10.1056/NEJMoa1906661)| false
RedantS, De BelsD, HonoréPM: Rationale of blood purification in the post-resuscitation syndrome following out-of-hospital cardiac arrest: A narrative review. Blood Purif50: 750–757, 2021https://doi.org/10.1159/000510127PubMed
RedantS, De BelsD, HonoréPM: Rationale of blood purification in the post-resuscitation syndrome following out-of-hospital cardiac arrest: A narrative review. Blood Purif 50: 750–757, 2021https://doi.org/10.1159/000510127PubMed10.1159/000510127)| false
KoxM, WaaldersNJB, KooistraEJ, GerretsenJ, PickkersP: Cytokine levels in critically ill patients with COVID-19 and other conditions. JAMA324: 1565, 2020https://doi.org/10.1001/jama.2020.17052PubMed
BossK, JahnM, WendtD, HaidariZ, DemirciogluE, ThielmannM, et al.: Extracorporeal cytokine adsorption: significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery. PLoS One16: e0246299, 2021https://doi.org/10.1371/journal.pone.0246299PubMed
BossK, JahnM, WendtD, HaidariZ, DemirciogluE, ThielmannM, : Extracorporeal cytokine adsorption: significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery. PLoS One 16: e0246299, 2021https://doi.org/10.1371/journal.pone.0246299PubMed10.1371/journal.pone.0246299)| false
